Satraplatin in the treatment of hormone-refractory prostate cancer.
Sternberg
Cora N
CN
Department of Medical Oncology, San Camillo and Forlanini Hospitals, Nuovi Padiglioni, Circonvallazione Gianicolense 87, 00152 Rome, Italy. cstern@mclink.it
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018572:Disease-Free Survival; D006801:Humans; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage*; D011239:Prednisolone / Q000008:administration & dosage; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D009944:Organoplatinum Compounds; C081294:satraplatin; D011239:Prednisolone